Distinguishing Ovarian and Uterine Primary Malignancies

Introduction to Diagnostic Approaches

• The British Journal of Cancer recommends adequate tissue sampling from both ovaries and uterus, including multiple well-directed samples from all ovarian lesions, for accurate diagnosis of primary ovarian cancer versus primary uterine cancer with ovarian metastasis 1, 2, 3

Surgical Pathology Requirements

• The National Comprehensive Cancer Network suggests that peritoneal biopsies alone are insufficient for diagnosis and do not provide proof of ovarian origin or degree of malignancy 1, 2
• A complete examination of both organs with detailed macroscopic and microscopic descriptions is necessary for accurate diagnosis 1, 2, 3

Tumor Marker Patterns

• The American College of Obstetricians and Gynecologists recommends measuring CA-125, which is elevated in approximately 85% of advanced ovarian cancer, but only 50% of early-stage cases 4
• A CA-125/CEA ratio >25 favors ovarian origin over gastrointestinal origin 4

Imaging Characteristics

• The National Comprehensive Cancer Network recommends CT or MRI with contrast to assess the pattern of disease spread 6, 7

Diagnostic Pitfalls

• The Annals of Oncology notes that metastatic adenocarcinomas, especially mucinous types, can closely mimic primary ovarian adenocarcinomas, making diagnosis challenging 8, 9
• Relying solely on CA-125 or single immunohistochemical markers can lead to diagnostic errors, and a comprehensive panel is essential 5

Recommended Diagnostic Algorithm

• Obtain adequate surgical specimens from both ovaries and uterus with multiple samples, and perform detailed macroscopic examination documenting size, laterality, surface involvement, and pattern of spread 1, 2, 3
• Measure a comprehensive tumor marker panel, including CA-125, CEA, and CA 19-9, and apply an immunohistochemical panel with CK7, CK20, ER, PR, and PAX8 4, 5